The investment seeks the balanced accomplishment of three objectives: long-term growth of capital, conservation of principal and current income... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ModerateAllocation
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HIO | 3.90 | 0.01 | +0.26% |
| Western Asset High Income Opportunity Fund | |||
| BSJV | 26.31 | -0.05 | -0.20% |
| Invesco BulletShares 2031 HY Corp Bd ETF | |||
| USIG | 50.71 | -0.23 | -0.45% |
| iShares Broad USD Invm Grd Corp Bd ETF | |||
| SPLB | 22.10 | -0.21 | -0.94% |
| SPDR® Portfolio Long Term Corp Bd ETF | |||
| XPH | 41.43 | -0.63 | -1.50% |
| SPDR® S&P Pharmaceuticals ETF | |||
A.I.dvisor indicates that over the last year, CBFCX has been closely correlated with RIRCX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if CBFCX jumps, then RIRCX could also see price increases.
| Ticker / NAME | Correlation To CBFCX | 1D Price Change % | ||
|---|---|---|---|---|
| CBFCX | 100% | -0.64% | ||
| RIRCX - CBFCX | 95% Closely correlated | -0.73% | ||
| CIREX - CBFCX | 95% Closely correlated | -0.73% | ||
| CIRAX - CBFCX | 95% Closely correlated | -0.71% | ||
| RIREX - CBFCX | 95% Closely correlated | -0.71% | ||
| RIRGX - CBFCX | 95% Closely correlated | -0.73% | ||
More | ||||